Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antibiotic Prophylaxis for ERCP: a Comparison of Intravenous Ceftriaxone With Intravenous Moxifloxacin in the Prophylaxis of Cholangitis

NCT02098486 is registered in ClinicalTrials.gov with Kangbuk Samsung Hospital as lead sponsor.

NCT NCT02098486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02098486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antibiotic Prophylaxis for ERCP: a Comparison of Intravenous Ceftriaxone With Intravenous Moxifloxacin in the Prophylaxis of Cholangitis
Lead sponsor
Kangbuk Samsung Hospital
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2014
Completion date
September 30, 2015
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangitis